Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2012
03/08/2012CA2809747A1 Compositions and methods for treating friedreich's ataxia with interferon gamma
03/08/2012CA2809535A1 Antifungal composition
03/08/2012CA2809321A1 Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
03/08/2012CA2808908A1 Combination of hdac inhibitors with thrombocytopenia drugs
03/08/2012CA2807448A1 Tetranectin-apolipoprotein a-i, lipid particles containing it and its use
03/08/2012CA2807441A1 Method for producing a lipid particle, the lipid particle itself and its use
03/08/2012CA2807433A1 Method for producing a lipid particle, the lipid particle itself and its use
03/07/2012EP2426196A1 Methods of making modular fusion protein expression products
03/07/2012EP2426140A1 Identification of porphyromonas gingivalis virulence polynucleotides in the diagnosis, treatment, and monitoring periodontal diseases
03/07/2012EP2426139A1 CXCR4 antagonist and use thereof
03/07/2012EP2425847A1 Methods of treating cancer using IL-21 and monoclonal antibody therapy
03/07/2012EP2425846A1 Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer's disease
03/07/2012EP2425845A1 Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer's disease
03/07/2012EP2425838A2 Combination therapy for treatment of immune disorders
03/07/2012EP2424978A1 Compositions and methods for modulating stem cells and uses thereof
03/07/2012EP2424898A1 Gm-csf and interleukin-21 conjugates and uses thereof in the modulation of immune response and treatment of cancer
03/07/2012EP2424885A2 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis
03/07/2012EP2424561A2 Methods for treating ocular conditions
03/07/2012EP2424560A1 Compounds and methods for modulating an immune response
03/07/2012EP2424559A1 Methods of treating bacterial infections using oritavancin
03/07/2012EP2424558A2 Sustained release formulations comprising gnrh analogues
03/07/2012EP2424557A1 Modified compstatin with peptide backbone and c-terminal modifications
03/07/2012EP2424556A1 Sustained release formulations of peptidomimetic drugs and uses thereof
03/07/2012EP2424384A1 Method for controlling the digestive coagulation of proteins
03/07/2012EP2297197B1 Modified erythropoietin (epo)polypeptides that exhibit increased protease resistance and pharmaceutical compositions thereof
03/07/2012EP2186830B1 Polyethylene glycol modified interferon alpha 2b and preparation method and applicatioins thereof
03/07/2012EP2079847B1 Use of lysozyme hydrolysates containing tryptophan
03/07/2012EP1901773B1 Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection
03/07/2012EP1767546B1 Angiogenesis-inhibiting chimeric protein and the use
03/07/2012EP1715884B1 Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
03/07/2012EP1713907B1 Hybrid proteins of active-site serine beta-lactamase.
03/07/2012EP1686957B1 Compositions containing mixtures of tetrapeptides and tripeptides
03/07/2012EP1638525B1 Inhalable formulations for treating pulmonary hypertension and methods of using same
03/07/2012EP1583506B1 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
03/07/2012EP1519732B1 Use of vasopeptidase inhibitors in the treatment of nephropathy
03/07/2012EP1355923B1 Immunomodulatory peptides derived from heat shock proteins and uses thereof
03/07/2012EP1289540B1 Oncomodulin for treating neurological disorders
03/07/2012CN1946388B Use of nitric oxide precursors in medicine preparation
03/07/2012CN1549721B Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
03/07/2012CN102369296A Mirac proteins
03/07/2012CN102369281A HLA-A24-binding cancer antigen peptide derived from SOX2
03/07/2012CN102369242A Polyion complex comprising hydrophobized polyamino acid and use of same
03/07/2012CN102369220A Target-activated cell/tissue-penetrating peptide for delivery of impermeable compounds and use thereof
03/07/2012CN102369212A Bone morphogenetic protein 2 (bmp2) variants with reduced bmp antagonist sensitivity
03/07/2012CN102369020A Novel uses of fibrinogen
03/07/2012CN102369019A Fast-acting insulin formulation
03/07/2012CN102369018A Treatment of diabetes and metabolic syndrome
03/07/2012CN102369017A Compositions and methods for minimally-invasive systemic delivery of proteins including tgf-ss superfamily members
03/07/2012CN102369016A Peripheral administration of proteins including tgf-ss superfamily members for treatment of systemic disorders and disease
03/07/2012CN102369015A Peptides, pharmaceutical compositions comprising same and uses thereof
03/07/2012CN102369014A Method of modulating HSF-1
03/07/2012CN102367277A Polymer conjugates of mutated neublastin
03/07/2012CN102367269A Caspofungin analogue, its preparation method and application
03/07/2012CN102367268A Caspofungin analogue and use thereof
03/07/2012CN102367266A Oligopeptide B and its antibacterial application
03/07/2012CN102367265A Oligopeptide D and antimicrobial application thereof
03/07/2012CN102366628A Quality stabilization technique of antitumor protein medicines
03/07/2012CN102366627A Protein sensitizer of tumor chemotherapeutics
03/07/2012CN102366410A Argatroban liposome injection
03/07/2012CN102008714B Ointment for promoting rapid healing of scabby chilblain
03/07/2012CN101816627B Synergistic treatment type multi-material sustained-release eye drop and preparation method
03/07/2012CN101735306B Anti-inflammatory peptide with membrane penetration effect
03/07/2012CN101716332B Use of phycocyanin for preventing and treating diabetes mellitus
03/07/2012CN101716331B Method for embedding protein biological macromolecules by using amylopectin-p-nitrocinnamic acid graft in situ
03/07/2012CN101426530B Wound healing polymer compositions and methods for use thereof
03/07/2012CN101143131B Method for preparing human insulin inhaled dry powder using with supercritical fluid technology
03/07/2012CN101116744B Combination neisserial compositions
03/07/2012CN101115496B Methods for improving the structure and function of arterioles
03/06/2012US8129561 Processes for intermediates for macrocyclic compounds
03/06/2012US8129518 Synthetic polysaccharide antigens for immunological intervention in disease
03/06/2012US8129517 Labeled solid supports for organic synthesis
03/06/2012US8129506 Modulation of the interaction of MUC1 with MUC1 ligands
03/06/2012US8129504 Oral delivery of modified transferrin fusion proteins
03/06/2012US8129500 Porphyromonas gingivalis polypeptides and nucleotides
03/06/2012US8129499 Antiviral peptides against influenza virus
03/06/2012US8129422 Methods and compositions for increasing the anaerobic working capacity in tissues
03/06/2012US8129354 Alzheimer's, Parkinson's, multiple sclerosis, schizophrenia, epilepsy, depression and pain
03/06/2012US8129353 Methods of gene therapy using nucleic acid sequences for ATP-binding cassette transporter
03/06/2012US8129351 for treatment of atopic conditions (dermatitis, allergies) and influenza virus; point mutations
03/06/2012US8129349 compositions and methods to suppress the activation and/or proliferation of mesenchymally derived cells, as well as cells with abnormal growth characteristics; inhibit or eliminate fibrosis; cancer
03/06/2012US8129348 Conjugates of biologically active proteins having a modified in vivo half-life
03/06/2012US8129347 Methods for treating autoimmune diseases using B7-H4 polypeptides and fragments thereof
03/06/2012US8129346 Compounds for enzyme inhibition
03/06/2012US8129345 MUC1-IκB kinase complexes and their activities
03/06/2012US8129344 Method of reducing cell death by administering a Sfrp polypeptide
03/06/2012US8129343 Acylated GLP-1 compounds
03/06/2012US8129342 High purity lipopeptides
03/06/2012US8129341 Methods for treating diabetic wounds
03/06/2012US8129340 Inhibitors of protein phosphatase 1, GADD34 and protein phosphatase 1/GADD34 complex, preparation and uses thereof
03/06/2012US8129339 Microencapsulation and sustained release of biologically active polypeptides
03/06/2012US8129337 EGCG, a protein hydrolysate and Coenzyme Q-10; orEGCG, a protein hydrolysate and resveratrol; orEGCG, a protein hydrolysate, ligustilide or other phthalides or herbal extracts containing ligustilide or other phthalides, and Coenzyme Q-10; antidiabetic agent ( insulin or non-insulin dependent diabetes)
03/06/2012US8129335 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
03/06/2012US8129332 Reagents and methods for smooth muscle therapies
03/06/2012US8129331 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT
03/06/2012US8129330 Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
03/06/2012US8129167 UL16 binding protein 4
03/06/2012US8128963 Methods for treating ischemic disorders using carbon monoxide
03/06/2012US8128939 Mutants of cholesterol-dependent cytolysins and uses thereof
03/06/2012US8128935 DNA sequence and recombinant production of the grass pollen allergen Phl p 4
03/06/2012US8128925 Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
1 ... 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 ... 3163